Neuros Medical


Neuros Medical develops and commercializes an implantable, patient‑controlled electrical neuromodulation system for treatment of chronic post‑amputation lower‑limb pain. The company completed a multicenter randomized pivotal study (QUEST), has peer‑reviewed 3‑ and 12‑month publications, and received U.S. FDA approval and Breakthrough Device designation for its implantable neuromodulation therapy. The organization also provides provider training, patient education, and reimbursement support.

Industries

Financial Services
Health Care
Life Science
Medical
Medical Device
Neuroscience
Therapeutics
Medical Equipment Manufacturing

Nr. of Employees

small (1-50)

Neuros Medical


Patents

Nerve cuff deployment devices

US-11752331-B2

View Details

Nerve cuff deployment devices

US-11116965-B2

View Details

High-frequency electrical nerve block

US-8983612-B2

View Details

High-frequency electrical nerve block

US-8731676-B2

View Details

Products

Implantable neuromodulation system (pulse generator + nerve cuff + patient controller)

An implanted system comprising a subcutaneous pulse generator, peripheral nerve cuff electrode, an external rechargeable charging interface, and a handheld patient controller to deliver on‑demand electrical stimulation for chronic post‑amputation pain.

Altius

An implantable neurostimulation system designed to treat chronic post-amputation pain such as phantom limb pain and residual limb pain by delivering electrical stimulation directly to damaged nerves.


Services

Training for clinicians on implantation and management of implantable nerve stimulation therapy.

Assistance with insurance prior authorization and reimbursement for eligible patients.

Provision of patient manuals, instructional videos, and educational materials for device use, charging, and daily living with an implant.

Expertise Areas

  • Neuromodulation therapy development
  • Clinical trial design and execution (pivotal multicenter RCTs)
  • Regulatory strategy and FDA PMA submissions
  • Implantable medical device engineering
  • Show More (4)

Key Technologies

  • Direct electrical nerve stimulation
  • High‑frequency bioelectric nerve block
  • Implantable pulse generator (IPG)
  • Peripheral nerve cuff electrodes
  • Show More (4)

News & Updates

Publication of 12‑month results from the QUEST randomized trial showing sustained pain reduction, decreased opioid use, and improved quality of life in lower‑limb amputees.

Announcement of U.S. FDA approval based on pivotal QUEST study results.

Acceptance and summary of primary 3‑month outcomes from the QUEST randomized controlled trial showing acute and short‑term benefits.

Press release announcing first commercial implantation of the implantable neuromodulation system.

Press releases noting Series BB and Series D capital raises to support completion of pivotal study and commercialization.

FDA approval of the implantable direct electrical nerve stimulation system for chronic post‑amputation lower‑limb pain.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.